Veterinary Diagnostics & Equipment: The Global Market

Table of Contents

CHAPTER 1 INTRODUCTION

CHAPTER 2 DEVICES AND DIAGNOSTIC EQUIPMENT

• 2.1 Introduction
• 2.2 Hematology analysis
  • 2.2.1 Automated hematology analyzers
  • 2.2.2 Coagulation analyzers
  • 2.2.3 Blood typing kits
• 2.3 Biochemistry analysis
  • 2.3.1 Biochemistry systems
  • 2.3.2 Dry chemistry systems
  • 2.3.3 Blood gas analyzers
  • 2.3.4 Electrolyte analysis
  • 2.3.5 Lactate meters
  • 2.3.6 Glucose meters
  • 2.3.7 Immunoassays
    • 2.3.7.1 Competitive immunoassays
    • 2.3.7.2 Sandwich immunoassays
    • 2.3.7.3 Animal-site rapid immunoassays
  • 2.3.8 DNA testing
  • 2.3.9 Bile acid tests and others
  • 2.3.10 Urine test kits
  • 2.3.11 Refractometers
• 2.4 Blood pressure monitors
• 2.5 Pulse oximeters
  • 2.5.1 Digital oximeters
• 2.6 Capnography
• 2.7 Vital signs monitors
• 2.8 Anesthesiology equipment
  • 2.8.1 Anesthetic machines
    • 2.8.1.1 Breathing systems
  • 2.8.2 Ventilators
  • 2.8.3 Anesthetic agents
• 2.9 Radiography
  • 2.9.1 Digital radiography
  • 2.9.2 Computed tomography
  • 2.9.3 Dental radiography
  • 2.9.4 Peripherals and consumables
• 2.10 Diagnostic ultrasound
  • 2.10.1 Large animal reproduction
  • 2.10.2 Small animal reproduction
  • 2.10.3 Equine tendon
  • 2.10.4 Cardiology
  • 2.10.5 Ophthalmology
  • 2.10.6 Ultrasound systems
  • 2.10.7 Three dimensional ultrasound
• 2.11 Magnetic resonance imaging
• 2.12 Other imaging
  • 2.12.1 Gamma cameras
  • 2.12.2 Dermatology imaging
  • 2.12.3 PACS
• 2.13 Endoscopes
  • 2.13.1 Laparoscopes
  • 2.13.2 Tract endoscopes
  • 2.13.3 Gastroscopes
  • 2.13.4 Bronchoscopes
  • 2.13.5 Thoracoscopes
  • 2.13.6 Cystoscopes
  • 2.13.7 Otoscopes
  • 2.13.8 Rhinoscopes

CHAPTER 3 COMPANY PROFILES

• 3.1 Abaxis
• 3.2 Abbott Laboratories
• 3.3 Adiagene
• 3.4 Agrolabo
• 3.5 ALerCHEK
• 3.6 Aloka
• 3.7 Ampronix
• 3.8 Biogal Galed Laboratories
• 3.9 BioMedica Diagnostics
• 3.10 Biomedica Group
• 3.11 Biovet
• 3.12 Bio Veto Test
• 3.13 BioX Diagnostics
• 3.14 Chembio Diagnostic Systems
• 3.15 Coris Bioconcept
• 3.16 Diatron
• 3.17 Digicare Biomedical Technology
• 3.18 Drew Scientific
• 3.19 Eklin Medical
• 3.20 Esaote
• 3.21 Euroclone
• 3.22 EVL
• 3.23 Fujifilm
• 3.24 GE Healthcare
• 3.25 Genzyme Virotech
• 3.26 Guildhay
• 3.27 Hallmarq Veterinary Imaging
• 3.28 Hemagen Diagnostics
• 3.29 Heska Corporation
• 3.30 Hitachi Medical
• 3.31 Honda Electronics
• 3.32 Hong Kong DNA Chips
• 3.33 IDEXX
• 3.34 Ingenasa
• 3.35 Institut Pourquier
• 3.36 Kruuse
• 3.37 Kyoritsu Seiyaku
• 3.38 Laboratorios Hipra
• 3.39 Makromed
• 3.40 Medison
• 3.41 Medivance (Velopex International)
• 3.42 Medlink Imaging
• 3.43 MegaCor Diagnostik
• 3.44 Melet Schloesing
• 3.45 Midland BioProducts
• 3.46 Mindray
• 3.47 Nonin Medical
• 3.48 PetScreen
• 3.49 Prionics
• 3.50 Qiagen
• 3.51 Richard Wolf
• 3.52 S & B Medvet
• 3.53 Scil Animal Care Company
• 3.54 Sharn Veterinary
• 3.55 Siemens Medical
• 3.56 Summit Industries
• 3.57 Storz
• 3.58 Svanova Biotech
• 3.59 Synbiotics
• 3.60 Sysmex
• 3.61 Thames Medical
• 3.62 Toshiba Medical Systems
• 3.63 TREK Diagnostic Systems
• 3.64 Tridelta
• 3.65 Ultrasound Technologies
• 3.66 United Biomedical
• 3.67 Vet Biotechnology
• 3.68 Vetronic Services
• 3.69 VetSpecs
• 3.70 Viral Antigens
• 3.71 Vita-Tech

CHAPTER 4 MARKETS

• 4.1 Introduction
• 4.2 Global animal health market
• 4.3 Global diagnostics and devices market
  • 4.3.1 Diagnostic and device customers
  • 4.3.2 Role of state laboratories
• 4.4 Global animal health industry
  • 4.4.1 Animal health industry and diagnostics
• 4.5 Global veterinary devices and diagnostics industry
• 4.6 Global regulation
  • 4.6.1 ISO
  • 4.6.2 DICOM
• 4.7 Market drivers
  • 4.7.1 Growth in companion animal sector
  • 4.7.2 Lack of regulation
  • 4.7.3 Shift to preventative healthcare
  • 4.7.4 Eradication programs
  • 4.7.5 Horses
  • 4.7.6 Continuing Professional Development
• 4.8 Market constraints
  • 4.8.1 Immature market
  • 4.8.2 State control
  • 4.8.3 Lack of expertise
  • 4.8.4 Lack of regulation
  • 4.8.5 Decline of livestock industry
  • 4.8.6 Unpredictability of disease outbreaks
  • 4.8.7 Costs
• 4.9 North America
  • 4.9.1 Market features
  • 4.9.2 Industry associations
  • 4.9.3 Regulation
    • 4.9.3.1 Recommendations
    • 4.9.3.2 Exceptions
• 4.10 Europe
  • 4.10.1 Market features
    • 4.10.1.1 Framework Programme 7
  • 4.10.2 Industry associations
  • 4.10.3 Regulation
    • 4.10.3.1 European Physical Agents Directive
• 4.11 Japan/Asia
  • 4.11.1 Market features
  • 4.11.2 Regulation
  • 4.11.3 Other Asia

CHAPTER 5 THERAPEUTIC AREAS

• 5.1 Major animal diseases and available tools
  • 5.1.1 Allergies
  • 5.1.2 Avian influenza
  • 5.1.3 Bovine tuberculosis
  • 5.1.4 Cardiac disease
  • 5.1.5 Cancer
  • 5.1.6 Cushing' s disease
  • 5.1.7 Diabetes
  • 5.1.8 Feline immunodeficiency virus
  • 5.1.9 Foot and mouth disease
  • 5.1.10 Heartworm
  • 5.1.11 Johne' s disease
  • 5.1.12 Mycoplasmas
  • 5.1.13 Navicular syndrome
  • 5.1.14 Parvovirus
  • 5.1.15 Transmissible spongiform encephalopathies
• 5.2 Therapeutic areas
  • 5.2.1 Endoscopy
    • 5.2.1.1 Otoscopy
    • 5.2.1.2 Arthroscopy
  • 5.2.2 Laparoscopy
    • 5.2.2.1 Cryptorchid castration
    • 5.2.2.2 Prophylactic gastropexy
    • 5.2.2.3 Ovariohysterectomy
    • 5.2.2.4 Other laparoscopy
  • 5.2.3 Ultrasound
  • 5.2.4 Electronic physiotherapy
  • 5.2.5 Laser therapy
  • 5.2.6 Pacemakers
  • 5.2.7 Artificial hips

CHAPTER 6 FUTURE TRENDS

• 6.1 Livestock trends
  • 6.1.1 DNA-based products
  • 6.1.2 Food safety
  • 6.1.3 Multiple diagnostics
  • 6.1.4 Field diagnostics
• 6.2 Companion animals
  • 6.2.1 Proteomics
  • 6.2.2 Integrated disease management
  • 6.2.3 Food allergies
  • 6.2.4 Capsule endoscopy
  • 6.2.5 Non-invasive devices
  • 6.2.6 Nanotechnology

REFERENCES

LIST OF TABLES

• Table 2.1 Common reagents used in veterinary biochemistry analyzers
• Table 2.2 Electrolyte imbalances and possible causes in companion animals
• Table 2.3 Diseases that produce microalbuminuria in cats and dogs
• Table 4.1 Geography of the world animal health market, 2004
• Table 4.2 World animal health market by species, 2004
• Table 4.3 Global diagnostics market by region
• Table 4.4 Top 15 veterinary pharmaceutical companies, 2004
• Table 4.5 Top 20 veterinary device and diagnostic firms
• Table 4.6 Regulatory approval needed for major Heska products
• Table 4.7 Pet ownership in the US
• Table 4.8 Sales of veterinary diagnostic products in Japan, ¥ million